Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 368

    Roches Alecensa wins EU panels nod against mutated lung cancer

    Roches Alecensa wins EU panels nod against mutated lung cancer

    Ruby Khatun Khatun17 Oct 2017 9:37 AM IST
    ZURICH: Swiss drugmaker Roche’s Alecensa has been recommended for approval in Europe as a first-line treatment for mutated lung cancer, a key European...
    Regeneron, Sanofi drug succeeds mid-stage study

    Regeneron, Sanofi drug succeeds mid-stage study

    Ruby Khatun Khatun17 Oct 2017 9:15 AM IST
    Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the...
    Pharma companies may post better results in Q2 on local biz growth

    Pharma companies may post better results in Q2 on local biz growth

    Ruby Khatun Khatun16 Oct 2017 10:31 AM IST
    Mumbai: Indian pharmaceutical companies are expected to post better results in the second quarter of the current fiscal, following the recovery in the...
    Lumenis launches its first ever M22 OPT technology for dry and itchy eyes caused by eyelid inflammation

    Lumenis launches its first ever M22 OPT technology for dry and itchy eyes caused by eyelid inflammation

    Ruby Khatun Khatun16 Oct 2017 10:07 AM IST
    New Delhi: With an increasing use of gadgets like mobiles phones, laptops and computers workaholic people are more prone to dry eye syndrome. Studies...
    GlaxoSmithKline shingles vaccine gets approval in Canada

    GlaxoSmithKline shingles vaccine gets approval in Canada

    Ruby Khatun Khatun16 Oct 2017 9:48 AM IST
    Canadian health regulators have approved GlaxoSmithKline’s key shingles vaccine, the company said on Friday.Shingrix, the British pharma company’s...
    Merck says will not seek approval of cholesterol treatment

    Merck says will not seek approval of cholesterol treatment

    Ruby Khatun Khatun16 Oct 2017 9:23 AM IST
    Merck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile...
    Apollo Hospitals joins hands with Samsung to fight non-communicable diseases in India

    Apollo Hospitals joins hands with Samsung to fight non-communicable diseases in India

    Ruby Khatun Khatun15 Oct 2017 10:35 AM IST
    Chennai: Samsung India, India’s biggest and most trusted consumer electronics and mobile phones brand, and Apollo Hospitals, Asia’s largest and most...
    Hilleman Labs achieves successful outcome of Phase I/II clinical trial of cholera vaccine

    Hilleman Labs achieves successful outcome of Phase I/II clinical trial of cholera vaccine

    Ruby Khatun Khatun15 Oct 2017 10:11 AM IST
    Hilleman Laboratories has announced the successful completion of Phase I/II Clinical Trials of its novel Oral Cholera Vaccine Hillchol. It was...
    Johnson and Johnson psoriasis drug gets expanded US approval for teens

    Johnson and Johnson psoriasis drug gets expanded US approval for teens

    Ruby Khatun Khatun15 Oct 2017 9:47 AM IST
    Johnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...
    Bayer to sell selected crop science biz to BASF for 7 billion dollar

    Bayer to sell selected crop science biz to BASF for 7 billion dollar

    Ruby Khatun Khatun15 Oct 2017 9:21 AM IST
    New Delhi: German drug and agrochemicals major Bayer on Friday announced the sale of selected crop science businesses to BASF for USD 7 billion as...
    Ardelyxs constipation drug succeeds in late-stage trial

    Ardelyxs constipation drug succeeds in late-stage trial

    Ruby Khatun Khatun15 Oct 2017 9:00 AM IST
    Ardelyx Inc said a second late-stage trial of its drug for irritable bowel syndrome with constipation (IBS-C) met the main goal of reducing abdominal...
    Zydus Cadila gets USFDA approval for anti-depression drug

    Zydus Cadila gets USFDA approval for anti-depression drug

    Ruby Khatun Khatun14 Oct 2017 10:57 AM IST
    New Delhi: Drug firm Zydus Cadila on Thursday said it has received the final approval from the US health regulator to market desvenlafaxine...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok